Navigation Links
CRi Oosight(TM) Instrument Crucial in IVF Breakthrough Demonstrating a Correlation Between Non-Invasive Egg Metrics and Pregnancy
Date:6/16/2009

WOBURN, Mass., June 16 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) announced today that Oosight(TM), a non-invasive optical imaging system manufactured by CRi and widely used by embryologists as an aid in the field of in vitro fertilization (IVF), has been used in a groundbreaking study that investigated ways to select eggs most likely to produce a pregnancy.

Dr. Suha Kilani, senior scientist at IVF Australia in Sydney, led a group which included researchers from the School of Women's & Children's Health at the University of New South Wales. The group determined that while absolute predictive criteria for the selection of the best embryo for single-embryo transfer remain elusive, CRi's Oosight instrument provides a useful, non-invasive means to accurately measure characteristics of the egg to help identify the most viable embryo even before fertilization occurs. The results are the first to show a direct link between egg spindle characteristics and pregnancy.

"Extrapolation of these results would suggest that when a normal spindle is found, the chances of a pregnancy, if a high quality cleavage stage embryo follows, is greater than 65%," commented Dr. Kilani.

"We congratulate Dr. Kilani and her collaborators on the quality of their work. It is a significant step forward in improving methods of non-invasive grading criteria. This study adds to our knowledge of contributing factors to fertility and also validates the importance of good quantitative data as produced with the Oosight system. Such data are imperative if we are to make single-embryo transfer a reality, thereby greatly reducing the risks associated with multiple births," said Cathy Boutin, Product Manager at CRi.

CRi's Oosight systems based upon the company's original LC-PolScope technology can be seen at the European Society for Human Reproduction and Embryology conference in Amsterdam June 28 to July 2 in the Research Instrument's booth (number 95).

Oosight systems produce non-invasive, high-contrast images of the meiotic spindle and zona pellucida without the need for potentially harmful dyes or stains. In addition, these images contain quantitative data that indicate the relative order of structures within the spindle and zona. In this study, spindle density was significantly higher in those oocytes resulting in pregnancy.

The work by Dr. Kilani's group, "Are there non-invasive markers in human oocytes that can predict pregnancy outcome?" was published in March by Reproductive BioMedicine Online.

Cambridge Research & Instrumentation, Inc (CRi) is a biomedical imaging company providing innovative optical imaging solutions for over 20 years. CRi's multidisciplinary team is dedicated to providing comprehensive solutions and support enabling our customers to produce breakthroughs in research and medical care. With a focus on addressing customer needs coupled to a commitment to advancing the field of personalized medicine, CRi helps scientists and clinicians extract new disease-specific information from biological samples in the physiological, morphological, and biochemical context of intact tissues and organisms. CRi's award-winning innovations are being recognized for their novel and groundbreaking capabilities in academic research to pharmaceutical drug development to clinical medicine, including a 2009 Top 10 Medical Innovations of the Year award from Cleveland Clinic and a 2009 Frost and Sullivan Product Line Strategy award. Learn more at www.cri-inc.com.

For more information visit our website at www.cri-inc.com or contact:

Cathy Boutin

CRi Product Manager

35-B Cabot Road, Woburn, MA 01801 USA

Tel: +1-781-935-9099, extension 180, E-mail: cboutin@cri-inc.com


'/>"/>
SOURCE Cambridge Research and Instrumentation, Inc. (CRi)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Novare Announces Successful Series of Single Port Lap Band Procedures With RealHand(R) High Dexterity Instruments
2. Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
3. Study Finds Starion Instruments Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
4. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
5. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
6. Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
7. Kevin McHale Instrumental in Forming the Help Me Hear Foundation
8. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
9. Heart Disease Treatment Breakthrough
10. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
11. New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
(Date:2/23/2017)... BOSTON , Feb. 23, 2017 ... devices and services since 1997, is changing the ... modern technology providing patients with pro-active, custom-made solutions. ... desire for instant and affordable healthcare without walls, ... of high-level devices developed with healthcare professionals that ...
Breaking Medicine Technology:
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... announced an official 2017 partnership with The Jensie Gran Fondo of Marin. For ... and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... Los Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... the first two episodes of WE TV’s “Mama June: From Not to Hot,” which ... of TV notable, “Mama” June Shannon, known to millions from the 2012 reality television ...
(Date:2/23/2017)... ... 23, 2017 , ... EBSCO Information Services (EBSCO) ... for Health and Care Excellence (NICE) framework. The agreement allows purchasers from ... to search, order and purchase medical and healthcare-related content through GOBI ®, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... new, interactive publication where generations converge and explore the world from different perspectives. ... Dialog Magazine enables readers to gain understanding, increase empathy, and find greater happiness. ...
Breaking Medicine News(10 mins):